Info

Medcomp® was founded in 1978 to produce and market Vascular Access Catheters for acute hemodialysis. At that time, catheter technology was in its early stages of development. The designs were simple, consisting of a single lumen catheter for single needle dialysis or double lumen catheters for continuous flow dialysis. Since the early 80's, our engineering and applications expertise have been put to work to provide a superior catheter to meet the increasing demand for a better product for a changing market. Research and development by our in-house staff of engineers, working in conjunction with some of today's preeminent physicians in the field of vascular access, has allowed us to provide our customers with some of the most innovative vascular access technology available today. From our Canaud and Tesio® Catheters (Dr. Bernard Canaud, France and Dr. Franco Tesio, Italy) to our Raulerson Duo-Flow (Dr. J. Daniel Raulerson, USA) and our recent Split Cath® (Dr. Stephen Ash, USA), we are continually improving on existing technology by providing a biocompatible, durable, high flow catheter to suit every need. The medical community is encouraged to submit suggestions, opinions, or comments regarding product function, design or development. This philosophy has been the cornerstone of Medcomp®'s growth. Marketing and distribution of our vascular access products is accomplished through 11 United States distributors and over 85 International distributors. Medcomp® is a global market leader, tailoring our products and technology to the demands of several geographic markets. Current marketing networks and a wealth of intellectual property assure Medcomp®'s leadership in the years to come.